InferX Corporation Executive Management Team Expanded; Paul B. Silverman Joins
as CEO and President; Carl Eckstein Joins Board of Directors
STERLING, Va., Dec. 27, 2012
STERLING, Va., Dec. 27, 2012 /PRNewswire/ --InferX Corporation (OTC/PK: NFRX)
announced today an expanded senior executive management team to support the
company's ambitious growth plans developing new advanced predictive analytics
solutions in the rapidly growing analytics market addressing health care and
other key market sectors.
InferX pioneered and commercialized a powerful, proprietary suite of
predictive data analysis technologies and tools. The Company has two patents
issued and three additional patents recently awarded its second patent for its
real time, distributed predictive analytics and business intelligence system
and has three additional predictive analytics patents pending.
Paul B. Silverman has agreed to serve as President and CEO of InferX,
replacing B.K. Gogia who has been serving as Acting President & CEO after the
resignation in July 2012 of Vijay Suri as President and CEO of InferX. Mr.
Silverman will assume responsibility for overall InferX business operations,
including all InferX services, business intelligence solutions and 'predictive
analysis' driven solutions which are a growing segment of InferX's business.
"Next generation business analytics is today's IT revolution, changing
traditional rules of market, strategy, and operations analysis, driving
economic growth and exciting new opportunities," said Paul B. Silverman,
InferX President and CEO. "I foresee opportunities to use InferX's proprietary
agent-based predictive analytics technology to develop and deliver innovative
new health care analytics solutions reducing costs, and improving operations
and quality of today's health care services. Personalized medicine, improved
disease management protocols, new tools to reduce fraud, new applications in
all sectors- that is what lies ahead driven by new analytics solutions- InferX
plans to play a highly visible role in this market evolution," said Silverman.
Under the new management plan, InferX Founder B.K. Gogia, will serve as
Chairman, and also Executive Vice President leading InferX's Health Care
initiatives, a new division which will be responsible for managing current
health care projects in the evidence-based medicine and analytics arena,
working with major health care partners.
"We are pleased that we have attractedhighlyexperienced, successfulsenior
management executives to support InferX's growth, helping the Company address
the exciting, exponential growth health care analytics market," said B.K.
Gogia, InferX's Chairman.
Mr. Silverman has a highly diversified and successful track record spanning 35
years serving as an experienced CEO, senior corporate management executive,
global management consultant, public and private company CEO. Mr. Silverman
has more than 10 years senior global management consulting experience, serving
in senior management consulting positions with Coopers & Lybrand and Booz
Allen and Hamilton, and also serving as CEO for James Martin Strategy, Inc.
(JMS) co-managing all North American business operations for the
Amsterdam-based global management consulting services firm. Mr. Silverman also
has more than 18 years senior corporate management experience with leading
global information industry players including GTE, RCA, Xerox and Satellite
Business Systems (division of IBM), where heserved as General Manager of
International Services. Mr. Silverman accepted an appointment to serve as
Special Representative for the Virginia Israeli Advisory Board (VIAB) within
Governor Tim Kaine's office to identify, review and assist in attracting
Israeli-based defense, homeland security and next gen health care companies to
Mr. Silverman also serves as an Adjunct Professor at the R. H. Smith School of
Business at the University of Maryland where he teaches both MBA and
undergraduate strategy courses. Afrequent speaker at industry conferences and
user groups, Mr. Silverman has published many articles and OpEds on new
management directions, analytics, international business, market trends,
policy and business issues, and also publishes a blog
(www.paulbsilverman/blog). He is also the author of "Worm On A Chopstick
–Understanding Today's Entrepreneurial Age: Directions, Strategies, Management
Perspectives," an entrepreneurial management book sharing strategies and
perspectives helping entrepreneurial managers address emerging challenges and
opportunities Mr. Silverman holds a BS in Physics from CCNY and an MS in
Management from Polytechnic University of New York.
Carl Eckstein has also been appointed to serve as a member of the Board of
Directors and will also serve as a Senior Advisor. Carl Eckstein is Managing
Partner of Sundial Ventures, LLC, a business development firm. Mr. Eckstein
served as Managing Director of NextGen Capital I and II venture capital funds
and is now developing a new NextGen III venture capital fund
(www.nextgencapital.com). He has directly participated in 22 investments and
in some cases served as CEO of selected portfolio companies. He has over
thirty years of experience as a venture capitalist, consultant and the owner
of several software firms engaged in GIS and information technology
consulting. Mr. Eckstein's experience also includes serving as a principal
with Arthur Young, consultant at Price Waterhouse, and a systems engineer at
About InferX Corporation
InferX is the market leader in next generation distributed Predictive
Analytics and Business Intelligence Products and Solutions. InferX has
pioneered and commercialized a powerful, patented suite of advanced data
analytical solutions that improve corporate performance across the enterprise
in the healthcare, financial services, and government markets. InferX is
uniquely capable of delivering secure, real-time, and privacy preserving
intelligence and decision support — all without the need to move data. InferX
is headquartered in Sterling, VA.
For more information go to the InferX website www.inferx.com
Certain statements above, in press releases and NFRX officials oral statements
are "Forward-Looking Statements" (FLS) according to the Private Securities
Litigation Reform Act of 1995 (the "Act"). FLS include statements predictive
in nature, depending upon or referring to future events / conditions,
including words like "believes," "anticipates," "intends," "plans," "expects,"
and similar expressions. Statements concerning future financial performance
(revenues, earnings, and growth rates), ongoing business strategies /
prospects, and future actions, which may be provided by management, are also
FLS as defined by the Act. The actual and any future results, performance or
achievements of the Company, expressed or implied, may be materially different
and vary significantly for different reporting periods due to FLS that involve
known and unknown risks and other factors. See InferX's 10-K for 12/31/11 for
a discussion of those risks. Management believes that the assumptions made and
expectations reflected in the FLS are reasonable. There is no assurance that
the underlying assumptions will prove to be correct and the actual future
results may be different from expectations expressed above. These statements
are not guarantees of future performance. NFRX has no specific intention to
update these statements.
©2012 InferX Corporation. All rights reserved. All trademarks and company
names mentioned are the property of their respective owners.
SOURCE InferX Corporation
Contact: Stuart Smith, InferX Corporation, +1-512-267-2430,
Press spacebar to pause and continue. Press esc to stop.